Literature DB >> 9893810

Spatial cone activity distribution in diseases of the posterior pole determined by multifocal electroretinography.

U Kretschmann1, M Seeliger, K Ruether, T Usui, E Zrenner.   

Abstract

Thirty patients with a reduced central vision due to diseases of the posterior pole were examined with the VERIS system developed by Sutter and Tran (Vis Res 1992;32:433-446) to characterize the topography of electroretinographic (ERG) changes in comparison to the results in 30 normal volunteers. Diagnoses included Stargardt's macular dystrophy (SMD, n = 10), age-related macular degeneration (AMD, n = 5), cone dystrophy (CD, n = 5), central retinal vein occlusion (CRVO, n = 5), and autosomal dominant optic atrophy (ADOA, n = 5). The 61 local responses obtained from each subjects were grouped by eccentricity to form five concentric rings. The foveal ERG, originating from a central area of 2 degrees radius, was non-recordable or markedly diminished in all patients except those with optic atrophy, where amplitudes were found to be in the normal range. In patients with advanced stages of SMD, functional defects were larger and involved more peripheral areas than in patients with early stages of SMD or with AMD. A reduction of response amplitude even in the most peripheral ring (17-30.5 degrees eccentricity) was found in cone dystrophies and--moderately--in patients with advanced SMD and central retinal vein occlusion only. Prolonged implicit times were found in all but the patients in early stages of SMD and they were maximal in patients with CRVO. This study shows that the multifocal ERG (MFERG) can contribute to differential diagnosis of retinal diseases of the posterior pole especially in cases with a normal photopic Ganzfeld ERG.

Entities:  

Mesh:

Year:  1998        PMID: 9893810     DOI: 10.1016/s0042-6989(98)00071-6

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  17 in total

1.  Continuous monitoring of the stimulated area in multifocal ERG.

Authors: 
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  Multifocal ERG and VEP responses and visual fields: comparing disease-related changes.

Authors:  D C Hood; X Zhang
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  Clinical applications of multifocal electroretinography.

Authors:  U Kretschmann; M Bock; R Gockeln; E Zrenner
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

4.  Wide field multifocal and standard full field electroretinographic features of hemi retinal vein occlusion.

Authors:  Fiona Mary Dolan; Stuart Parks; David Keating; Gordon Neale Dutton
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

Review 5.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

6.  mfERG in normal and lesioned rabbit retina.

Authors:  Karin W Gjörloff; Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

7.  Vitamin A deficiency modifies the mfERG: a case study of rod influence on the mfERG.

Authors:  Fiona M Dolan; Teresa Sandinha; Alistair Purdy; Stuart Parks; David Keating
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

8.  Examination of short binary sequences for mfERG recording.

Authors:  Richard P Hagan; Anthony C Fisher; Malcolm C Brown
Journal:  Doc Ophthalmol       Date:  2006-08-30       Impact factor: 2.379

9.  ERGs, cone-isolating VEPs and analytical techniques in children with cone dysfunction syndromes.

Authors:  John P Kelly; Michael A Crognale; Avery H Weiss
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

10.  Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen.

Authors:  Christina Gerth; David Hauser; Peter B Delahunt; Lawrence S Morse; John S Werner
Journal:  Arch Ophthalmol       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.